Literature DB >> 315870

alpha 1-Antitrypsin deficiency and susceptibility to lung disease.

H E Evans, N Bognacki.   

Abstract

This subject concerns the complex interrelationship of a genetically determined protein deficiency, enzymes which are inhibited by that protein, environmental challenges such as cigarette smoke and industrial pollutants, and the occurrence of obstructive lung disease (Fig. 1). Unequivocal establishment of an etiological role for AAT deficiency, especially of intermediate degree, has proven to be difficult. Confounding variables such as enzyme concentration in PMN and PAMs, duration of exposure to potential environmental hazards, differences in laboratory methods utilized in measuring AAT and in studying pulmonary function all require investigation. The definitive study, incorporating all of these and other factors, has yet to be conducted. No single, clear-cut conclusion can be drawn from analysis of present studies. In those circumstances in which heterozygotes appear to be predisposed to COPD, phenotypic screening of the population at potential risk, such as industrial workers may be appropriate. Conversely, in conditions in which no association is demonstrated, such screening would not be justified. Perhaps, the best one can do is to suggest a "Scotch verdict"; that is, the issue of causation is not proven.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 315870      PMCID: PMC1637376          DOI: 10.1289/ehp.792957

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  22 in total

1.  Interactions of neutrophil elastase, serum trypsin inhibitory activity, and smoking history as risk factors for chronic obstructive pulmonary disease in patients with MM, MZ, and ZZ phenotypes for alpha-antitrypsin.

Authors:  M Galdston; E L Melnick; R M Goldring; V Levytska; C A Curasi; A L Davis
Journal:  Am Rev Respir Dis       Date:  1977-11

2.  Enzymatic production of experimental emphysema in the dog. Route of exposure.

Authors:  G Weinbaum; V Marco; T Ikeda; B Mass; D R Meranze; P Kimbel
Journal:  Am Rev Respir Dis       Date:  1974-03

3.  133 Xe ventilatory studies in 1-antitrypsin deficiency.

Authors:  R J Fallat; M R Powell; F Kueppers; E Lilker
Journal:  J Nucl Med       Date:  1973-01       Impact factor: 10.057

4.  Heterozygous and homozygous alpha1-antitrypsin deficiency in patients with pulmonary emphysema.

Authors:  J Lieberman
Journal:  N Engl J Med       Date:  1969-08-07       Impact factor: 91.245

5.  Pi phenotypes and the prevalence of chest symptoms and lung function abnormalities in workers employed in dusty industris.

Authors:  M Chan-Yeung; M J Ashley; P Corey; H Maledy
Journal:  Am Rev Respir Dis       Date:  1978-02

6.  Heterozygous alpha-1-antitrypsin deficiency and respiratory function in children.

Authors:  J C Vance; W J Hall; R H Schwartz; R W Hyde; K J Roghmann; G C Mudholkar
Journal:  Pediatrics       Date:  1977-09       Impact factor: 7.124

7.  Effect of human alpha-antitrypsin in papain-induced emphysema in the hamster.

Authors:  P A Martorana; N N Share
Journal:  Am Rev Respir Dis       Date:  1976-05

8.  Interrelationships between the human alveolar macrophage and alpha-1-antitrypsin.

Authors:  A B Cohen
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

9.  Human alveolar macrophage proteolytic enzyme activities in chronic obstructive pulmonary disease. Lack of correlation with functional abnormalities.

Authors:  W L Coudon; J O Harris
Journal:  Chest       Date:  1978-03       Impact factor: 9.410

10.  The relationship of childhood respiratory illness to adult obstructive airway disease.

Authors:  B Burrows; R J Knudson; M D Lebowitz
Journal:  Am Rev Respir Dis       Date:  1977-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.